Affiliation:
1. Hospital Israelita Albert Einstein, Brazil
Abstract
ABSTRACT The use of nanocarriers as drug delivery systems for therapeutic or imaging agents can improve the pharmacological properties of commonly used compounds in cancer diagnosis and treatment. Advances in the surface engineering of nanoparticles to accommodate targeting ligands turned nanocarriers attractive candidates for future work involving targeted drug delivery. Although not targeted, several nanocarriers have been approved for clinical use and they are currently used to treat and/or diagnosis various types of cancers. Furthermore, there are several formulations, which are now in various stages of clinical trials. This review examined some approved formulations and discussed the advantages of using nanocarriers in cancer therapy.
Reference30 articles.
1. Improving drug delivery to solid tumors: priming the tumor microenvironment;Khawar IA;J Control Release,2015
2. Nanocarriers as an emerging platform for cancer therapy;Peer D;Nat Nanotechnol,2007
3. Drug delivery systems: entering the mainstream;Allen TM;Science,2004
4. A new concept for macromolecular therapeutics in cancer- chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs;Matsumura Y;Cancer Res,1986
5. Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy;Pérez-Herrero E;Eur J Pharm Biopharm,2015
Cited by
60 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献